Revolution Medicines to Host Science Talk Webcast Highlighting Learnings from Recent Preclinical and Clinical Studies of RAS Inhibitors

NEXT STORY
Paratek Pharmaceuticals Hosting Investor Webinar with Corporate Updates and Key Opinion Leader and Patient Advocate Presentations on Non-Tuberculous Mycobacteria, M. abscessus
PREV STORY
Tonix Pharmaceuticals to Participate in BIO Digital Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AZ COMPLETES AGREEMENT WITH PERRIGO

ASTRAZENECA COMPLETES AGREEMENT WITH PERRIGO FOR RIGHTS TO ENTOCORT® IN THE US AstraZeneca today ...

author_avatar
NASDAQ Market News

Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine

Pediatric Study Demonstrated Improvements in Rickets Severity, Growth, Pain and Physical Activity in Children ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy:n oma pääoma negatiivinen marraskuun lopussa

FIT Biotech OyYhtiötiedote 19.12.2017 kello 15.00                               DRAFT FIT Biotech Oy:n oma pääoma negatiivinen marraskuun ...

author_avatar
NASDAQ Market News